These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35457099)

  • 21. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.
    Chen Z; Fitzgerald RL; Li G; Davidson NO; Schonfeld G
    J Lipid Res; 2004 Jan; 45(1):155-63. PubMed ID: 13130124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.
    Zhong S; Magnolo AL; Sundaram M; Zhou H; Yao EF; Di Leo E; Loria P; Wang S; Bamji-Mirza M; Wang L; McKnight CJ; Figeys D; Wang Y; Tarugi P; Yao Z
    J Biol Chem; 2010 Feb; 285(9):6453-64. PubMed ID: 20032471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
    Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
    J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.
    Tarugi P; Averna M
    Adv Clin Chem; 2011; 54():81-107. PubMed ID: 21874758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
    Di Filippo M; Moulin P; Roy P; Samson-Bouma ME; Collardeau-Frachon S; Chebel-Dumont S; Peretti N; Dumortier J; Zoulim F; Fontanges T; Parini R; Rigoldi M; Furlan F; Mancini G; Bonnefont-Rousselot D; Bruckert E; Schmitz J; Scoazec JY; Charrière S; Villar-Fimbel S; Gottrand F; Dubern B; Doummar D; Joly F; Liard-Meillon ME; Lachaux A; Sassolas A
    J Hepatol; 2014 Oct; 61(4):891-902. PubMed ID: 24842304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation.
    Martín-Campos JM; Roig R; Mayoral C; Martinez S; Martí G; Arroyo JA; Julve J; Blanco-Vaca F
    Clin Chim Acta; 2012 Mar; 413(5-6):552-5. PubMed ID: 22155345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S; Zaffanello M; Di Leo E; Costa L; Lonardo A; Tarugi P
    J Hepatol; 2005 Jul; 43(1):188-91. PubMed ID: 15894400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia.
    Burnett JR; Shan J; Miskie BA; Whitfield AJ; Yuan J; Tran K; McKnight CJ; Hegele RA; Yao Z
    J Biol Chem; 2003 Apr; 278(15):13442-52. PubMed ID: 12551903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rare Mutation in The
    Musialik J; Boguszewska-Chachulska A; Pojda-Wilczek D; Gorzkowska A; Szymańczak R; Kania M; Kujawa-Szewieczek A; Wojcieszyn M; Hartleb M; Więcek A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia.
    Rimbert A; Vanhoye X; Coulibaly D; Marrec M; Pichelin M; Charrière S; Peretti N; Valéro R; Wargny M; Carrié A; Lindenbaum P; Deleuze JF; Genin E; Redon R; Rollat-Farnier PA; Goxe D; Degraef G; Marmontel O; Divry E; Bigot-Corbel E; Moulin P; Cariou B; Di Filippo M
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e63-e71. PubMed ID: 33207932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
    Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypobetalipoproteinemias.
    Schonfeld G
    Annu Rev Nutr; 1995; 15():23-34. PubMed ID: 8527219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
    Burnett JR; Zhong S; Jiang ZG; Hooper AJ; Fisher EA; McLeod RS; Zhao Y; Barrett PH; Hegele RA; van Bockxmeer FM; Zhang H; Vance DE; McKnight CJ; Yao Z
    J Biol Chem; 2007 Aug; 282(33):24270-83. PubMed ID: 17588943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia.
    Di Leo E; Magnolo L; Pinotti E; Martini S; Cortella I; Vitturi N; Rabacchi C; Wunsch A; Pucci F; Bertolini S; Calandra S; Tarugi P
    Mol Genet Metab; 2009 Feb; 96(2):66-72. PubMed ID: 19084451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel APOB mutation in familial hypobetalipoproteinemia.
    Domenech M; Llano-Rivas I; Arroyo V; Ortega E
    J Clin Lipidol; 2022; 16(1):28-32. PubMed ID: 34852964
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial hypobetalipoproteinemia: a review.
    Schonfeld G
    J Lipid Res; 2003 May; 44(5):878-83. PubMed ID: 12639976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutations of APOB cause ApoB truncations undetectable in plasma and familial hypobetalipoproteinemia.
    Yue P; Yuan B; Gerhard DS; Neuman RJ; Isley WL; Harris WS; Schonfeld G
    Hum Mutat; 2002 Aug; 20(2):110-6. PubMed ID: 12124991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
    Tanoli T; Yue P; Yablonskiy D; Schonfeld G
    J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.